$heff's $tation of $tocks & $olid DD

[$heff]

PLX..$10.11 is moving strong today in a down market. Today's low was $9.80. Very impressed with the trading. I continue to see strength going into their Feb 25th PDUFA date. If there is a pullback I view it as a potential opportunity.

Message in reply to seller of PLX:

With PLX ($9.95) that seller could be a disgruntled shareholder as someone had reported that he has a history with TEVA & PLX. No one really knows, but what is important is that it does not affect the PDUFA date in front of the FDA or the company. We saw selling with AVNR in October by directors in the $3.00 range and investors were concerned as well. Many speculated it was because their pseudobulbar drug would not get approved. That was not the case and we got the approval of Nuedexta for Pseudobulbar Affect.
I am confident with the DD on this company. We have done our homework here and know what we own! The company (PLX) and the technology are solid and they have a large partner in Pfizer that is solid. If the recent selling concerns investors, then they should not buy shares of the company or any biotech for that matter as selling shares is becoming more the norm than not. That big investor selling shares may want to divert some of his holdings into another holding. I will note that just recently Baillie Gifford & Co (Scottish partnership)took at 7.18% stake in the company.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7354404


Best, $heff